0000930413-15-001806 | 10-Q | XBRL Viewer | Honeywell International INC

Print Document View Excel Document

REPOSITIONING AND OTHER CHARGES (Details) - USD ($)	3 Months Ended
REPOSITIONING AND OTHER CHARGES (Details) - USD ($)	Mar. 31, 2015	Mar. 31, 2014
Component Of Operating Other Cost And Expense [Line Items]
Total net repositioning charge	$ 39,000,000	$ 82,000,000
Asbestos related litigation charges, net of insurance	46,000,000	48,000,000
Probable and reasonably estimable environmental liabilities	46,000,000	82,000,000
Other	0	2,000,000
Total net repositioning and other charges	131,000,000	214,000,000
Severance Costs [Member]
Component Of Operating Other Cost And Expense [Line Items]
Total net repositioning charge	37,000,000	71,000,000
Tangible And Intangible Asset Impairment [Member]
Component Of Operating Other Cost And Expense [Line Items]
Total net repositioning charge	8,000,000	9,000,000
Exit Costs [Member]
Component Of Operating Other Cost And Expense [Line Items]
Total net repositioning charge	1,000,000	8,000,000
Restructuring Reserve Accrual Adjustments [Member]
Component Of Operating Other Cost And Expense [Line Items]
Total net repositioning charge	$ (7,000,000)	$ (6,000,000)

INVENTORIES

3 Months Ended

Mar. 31, 2015

Inventories [Abstract]

Inventories

Note 6. Inventories

		March 31,		December 31,
		2015		2014

Raw materials	$	1,088	$	1,124
Work in process		828		815
Finished products		2,708		2,634
		4,624		4,573
Reduction to LIFO cost basis		(117)		(168)
	$	4,507	$	4,405

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2015 shares
Document And Entity Information [Abstract]
Document type	10-Q
Document period end date	Mar. 31, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Amendment flag	false
Entity registrant name	Honeywell International Inc
Entity central index key	0000773840
Entity current reporting status	Yes
Entity voluntary filers	No
Current fiscal year end date	--12-31
Entity filer category	Large Accelerated Filer
Entity well known seasoned issuer	Yes
Entity common stock shares outstanding	781,707,489

PENSION BENEFITS (Details) - USD ($)	3 Months Ended
PENSION BENEFITS (Details) - USD ($)	Mar. 31, 2015	Mar. 31, 2014
United States, Defined Benefit [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 57,000,000	$ 60,000,000
Interest cost	178,000,000	193,000,000
Expected return on plan assets	(320,000,000)	(314,000,000)
Amortization of prior service cost	6,000,000	6,000,000
Net periodic benefit (income)	(79,000,000)	(55,000,000)
Non-US, Defined Benefit [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	13,000,000	14,000,000
Interest cost	44,000,000	58,000,000
Expected return on plan assets	(90,000,000)	(89,000,000)
Amortization of prior service cost	0	0
Net periodic benefit (income)	(33,000,000)	$ (17,000,000)
Cash contributions to pension plans	4,000,000
Marketable securities contributed to pension plan	$ 109,000,000

SEGMENT FINANCIAL DATA (Details) - USD ($) $ in Millions	3 Months Ended
SEGMENT FINANCIAL DATA (Details) - USD ($) $ in Millions	Mar. 31, 2015	Mar. 31, 2014
Reconciliation of segment profit to consolidated [Abstract]
Total segment profit	$ 1,721	$ 1,596
Other income (expense)	12	111
Interest and other financial charges	(77)	(79)
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Stock compensation expense	(52)	(52)
Repositioning and other charges	(131)	(214)
Income before taxes	1,564	1,411
Segment Reporting Information [Line Items]
Product sales	7,364	7,845
Service sales	1,849	1,834
Net Sales	9,213	9,679
Total segment profit	1,721	1,596
Aerospace [Member]
Reconciliation of segment profit to consolidated [Abstract]
Total segment profit	752	703
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Repositioning and other charges	(48)	(76)
Segment Reporting Information [Line Items]
Product sales	2,463	2,692
Service sales	1,144	1,159
Net Sales	3,607	3,851
Total segment profit	752	703
Automation and Control Solutions [Member]
Reconciliation of segment profit to consolidated [Abstract]
Total segment profit	516	471
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Repositioning and other charges	(24)	(46)
Segment Reporting Information [Line Items]
Product sales	2,979	3,075
Service sales	285	287
Net Sales	3,264	3,362
Total segment profit	516	471
Performance Materials And Technologies [Member]
Reconciliation of segment profit to consolidated [Abstract]
Total segment profit	503	473
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Repositioning and other charges	(7)	(14)
Segment Reporting Information [Line Items]
Product sales	1,922	2,078
Service sales	420	388
Net Sales	2,342	2,466
Total segment profit	503	473
Corporate [Member]
Reconciliation of segment profit to consolidated [Abstract]
Total segment profit	(50)	(51)
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Repositioning and other charges	(52)	(78)
Segment Reporting Information [Line Items]
Total segment profit	(50)	(51)
Pension Plans, Defined Benefit [Member]
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Benefit plans income/(expense)	100	61
Other Postretirement Benefit Plans [Member]
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Benefit plans income/(expense)	$ (9)	$ (12)

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES

3 Months Ended

Mar. 31, 2015

Financial Instruments And Fair Value Measures [Abstract]

Financial Instruments and Fair Value Measures

Note 8. Financial Instruments and Fair Value Measures

Our credit, market, foreign currency and interest rate risk management policies are described in Note 14, Financial Instruments and Fair Value Measures, of Notes to Financial Statements in our 2014 Annual Report on Form 10-K.

Financial and nonfinancial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis:

		March 31,		December 31,
		2015		2014
Assets:
Foreign currency exchange contracts	$	135	$	20
Available for sale investments		1,767		1,479
Interest rate swap agreements		108		93

Liabilities:
Foreign currency exchange contracts	$	29	$	10

The foreign currency exchange contracts and interest rate swap agreements are valued using broker quotations or market transactions in either the listed or over-the-counter markets. These derivative instruments are classified within level 2 of the fair value hierarchy. The Company holds investments in certificates of deposits, time deposits and commercial paper that are designated as available for sale and are valued using market transactions in over-the-counter markets. These investments are classified within level 2 of the fair value hierarchy.

The carrying value of cash and cash equivalents, trade accounts and notes receivables, payables, commercial paper and short-term borrowings contained in the Consolidated Balance Sheet approximates fair value. The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value:

	March 31, 2015				December 31, 2014
	Carrying		Fair		Carrying		Fair
	Value		Value		Value		Value
Assets
Long-term receivables	$	297	$	292	$	297	$	293
Liabilities
Long-term debt and related current maturities	$	6,965	$	7,813	$	6,985	$	7,817

The Company determined the fair value of the long-term receivables by discounting based upon the terms of the receivable and counterparty details including credit quality. These receivables are classified within level 2 of the fair value hierarchy. The Company determined the fair value of the long-term debt and related current maturities utilizing transactions in the listed markets for identical or similar liabilities. The long-term debt and related current maturities are also classified within level 2 of the fair value hierarchy.

We enter into transactions designed to provide for netting of offsetting obligations in the event of the insolvency or default of a counterparty. However, we have not elected to offset multiple contracts with a single counterparty, therefore the fair value of the derivative instruments in a loss position is not offset against the fair value of derivative instruments in a gain position.

Interest rate swap agreements are designated as hedge relationships with gains or losses on the derivative recognized in Interest and other financial charges offsetting the gains and losses on the underlying debt being hedged. For the three months ended March 31, 2015 and 2014, we recognized $15 million and $13 million of gains in earnings on interest rate swap agreements. Gains and losses are fully offset by losses and gains on the underlying debt being hedged.

We also economically hedge our exposure to changes in foreign exchange rates principally with forward contracts. These contracts are marked-to-market with the resulting gains and losses recognized in earnings offsetting the gains and losses on the non-functional currency denominated monetary assets and liabilities being hedged. We recognized $162 million of expense and $57 million of income in Other (Income) Expense for the three months ended March 31, 2015 and 2014.

PENSION BENEFITS

3 Months Ended

Mar. 31, 2015

Pension Disclosure Paragraph Details [Abstract]

Pension Benefits

Note 11. Pension Benefits

Net periodic pension benefit costs for our significant defined benefit plans include the following components:

		Three Months Ended
		U.S. Plans				Non-U.S. Plans
		March 31,				March 31,
		2015		2014		2015		2014

Service cost	$	57	$	60	$	13	$	14
Interest cost		178		193		44		58
Expected return on plan assets		(320)		(314)		(90)		(89)
Amortization of prior service cost		6		6		-		-
	$	(79)	$	(55)	$	(33)	$	(17)

In the first quarter of 2015, Honeywell contributed $109 million of marketable securities and $4 million of cash to our non-U.S. pension plans.

ACCOUNTS, NOTES AND OTHER RECEIVABLES

3 Months Ended

Mar. 31, 2015

Accounts, Notes And Other Receivables [Abstract]

Accounts, Notes and Other Receivables

Note 5. Accounts, Notes and Other Receivables


		March 31,		December 31,
		2015		2014

Trade	$	7,868	$	7,788
Other		557		445
		8,425		8,233
Less: Allowance for doubtful accounts		(267)		(273)
	$	8,158	$	7,960

Trade receivables include $1,730 and $1,636 million of unbilled balances under long-term contracts as of March 31, 2015 and December 31, 2014.

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References + Details

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Tables)

3 Months Ended

Mar. 31, 2015

Financial Instruments And Fair Value Measures [Abstract]

Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block

		March 31,		December 31,
		2015		2014
Assets:
Foreign currency exchange contracts	$	135	$	20
Available for sale investments		1,767		1,479
Interest rate swap agreements		108		93

Liabilities:
Foreign currency exchange contracts	$	29	$	10

Financial assets and liabilities that were not carried at fair value

	March 31, 2015				December 31, 2014
	Carrying		Fair		Carrying		Fair
	Value		Value		Value		Value
Assets
Long-term receivables	$	297	$	292	$	297	$	293
Liabilities
Long-term debt and related current maturities	$	6,965	$	7,813	$	6,985	$	7,817

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES 3 (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash Flow Hedge Gain Loss Reclassified To Income Statement Locations Paragraph Details [Abstract]
Gain (loss) on interest rate swap agreements	$ 15	$ 13
Foreign Exchange Mark to Market income (expense)	$ (162)	$ 57

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net income	$ 1,146,000,000	$ 1,036,000,000
Less: Net income attributable to the noncontrolling interest	30,000,000	19,000,000
Net income attributable to Honeywell	1,116,000,000	1,017,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:
Depreciation	163,000,000	168,000,000
Amortization	53,000,000	70,000,000
Gain on sale of available for sale investments	0	(105,000,000)
Repositioning and other charges	131,000,000	214,000,000
Net payments for repositioning and other charges	(100,000,000)	(125,000,000)
Pension and other postretirement income	(91,000,000)	(49,000,000)
Pension and other postretirement benefit payments	(9,000,000)	(36,000,000)
Stock compensation expense	52,000,000	52,000,000
Deferred income taxes	93,000,000	2,000,000
Excess tax benefits from share based payment arrangements	(47,000,000)	(30,000,000)
Other	(102,000,000)	(24,000,000)
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:
Accounts, notes and other receivables	(170,000,000)	(154,000,000)
Inventories	(86,000,000)	(115,000,000)
Other current assets	58,000,000	236,000,000
Accounts payable	(112,000,000)	(41,000,000)
Accrued liabilities	(528,000,000)	(392,000,000)
Net cash provided by operating activities	421,000,000	688,000,000
Cash flows from investing activities:
Expenditures for property, plant and equipment	(165,000,000)	(192,000,000)
Proceeds from disposals of property, plant and equipment	1,000,000	7,000,000
Increase in investments	(1,501,000,000)	(631,000,000)
Decrease in investments	1,106,000,000	410,000,000
Cash paid for acquisitions, net of cash acquired	(185,000,000)	0
Proceeds from sales of businesses, net of fees paid	2,000,000	0
Other	(178,000,000)	61,000,000
Net cash used for investing activities	(920,000,000)	(345,000,000)
Cash flows from financing activities:
Net increase in commercial paper	1,048,000,000	1,100,000,000
Net increase (decrease) in short-term borrowings	4,000,000	(10,000,000)
Proceeds from issuance of common stock	78,000,000	92,000,000
Proceeds from issuance of long-term debt	3,000,000	25,000,000
Payments of long-term debt	(35,000,000)	(602,000,000)
Excess tax benefits from share based payment arrangements	47,000,000	30,000,000
Repurchases of common stock	(363,000,000)	(320,000,000)
Cash dividends paid	(415,000,000)	(363,000,000)
Net cash provided by (used for) financing activities	367,000,000	(48,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents	(252,000,000)	(45,000,000)
Net (decrease) increase in cash and cash equivalents	(384,000,000)	250,000,000
Cash and cash equivalents at beginning of period	6,959,000,000	6,422,000,000
Cash and cash equivalents at end of period	$ 6,575,000,000	$ 6,672,000,000

REPOSITIONING AND OTHER CHARGES 5 (Details)	3 Months Ended
REPOSITIONING AND OTHER CHARGES 5 (Details)	Mar. 31, 2015 USD ($)
Restructuring Reserve [Line Items]
Balance at beginning of period,	$ 315,000,000
Charges	46,000,000
Usage - cash	(27,000,000)
Usage - noncash	(8,000,000)
Foreign currency translation adjustment	(11,000,000)
Adjustments	(7,000,000)
Balance at end of period,	308,000,000
Severance Costs [Member]
Restructuring Reserve [Line Items]
Balance at beginning of period,	285,000,000
Charges	37,000,000
Usage - cash	(24,000,000)
Usage - noncash	0
Foreign currency translation adjustment	(9,000,000)
Adjustments	(3,000,000)
Balance at end of period,	286,000,000
Tangible And Intangible Asset Impairment [Member]
Restructuring Reserve [Line Items]
Balance at beginning of period,	0
Charges	8,000,000
Usage - cash	0
Usage - noncash	(8,000,000)
Foreign currency translation adjustment	0
Adjustments	0
Balance at end of period,	0
Exit Costs [Member]
Restructuring Reserve [Line Items]
Balance at beginning of period,	30,000,000
Charges	1,000,000
Usage - cash	(3,000,000)
Usage - noncash	0
Foreign currency translation adjustment	(2,000,000)
Adjustments	(4,000,000)
Balance at end of period,	$ 22,000,000

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Accumulated Other Comprehensive Income Loss [Line Items]
Balance beginning of period December 31,	$ (1,459,000,000)	$ 818,000,000
Other comprehensive income (loss) before reclassifications	(616,000,000)	(7,000,000)
Amounts reclassified from accumulated other comprehensive income	(24,000,000)	(63,000,000)
Net current period other comprehensive income (loss)	(640,000,000)	(70,000,000)
Balance end of period	(2,099,000,000)	748,000,000
Foreign Exchange Translation Adjustment [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Balance beginning of period December 31,	(740,000,000)	304,000,000
Other comprehensive income (loss) before reclassifications	(721,000,000)	(5,000,000)
Amounts reclassified from accumulated other comprehensive income	0	0
Net current period other comprehensive income (loss)	(721,000,000)	(5,000,000)
Balance end of period	(1,461,000,000)	299,000,000
Pension and Other Postretirement Adjustments [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Balance beginning of period December 31,	(728,000,000)	355,000,000
Other comprehensive income (loss) before reclassifications	0	0
Amounts reclassified from accumulated other comprehensive income	3,000,000	4,000,000
Net current period other comprehensive income (loss)	3,000,000	4,000,000
Balance end of period	(725,000,000)	359,000,000
Changes in Fair Value of Available for Sale Investments [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Balance beginning of period December 31,	0	170,000,000
Other comprehensive income (loss) before reclassifications	0	(11,000,000)
Amounts reclassified from accumulated other comprehensive income	0	(71,000,000)
Net current period other comprehensive income (loss)	0	(82,000,000)
Balance end of period	0	88,000,000
Changes in Fair Value of Effective Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Balance beginning of period December 31,	9,000,000	(11,000,000)
Other comprehensive income (loss) before reclassifications	105,000,000	9,000,000
Amounts reclassified from accumulated other comprehensive income	(27,000,000)	4,000,000
Net current period other comprehensive income (loss)	78,000,000	13,000,000
Balance end of period	$ 87,000,000	$ 2,000,000

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References + Details

COMMITMENTS AND CONTINGENCIES 6 (Details) - Bendix Asbestos Loss Contingency Liability [Member] - claims	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Loss Contingency Disease Distribution Of Unresolved Claims [Line Items]
Mesothelioma and Other Cancer Claims	3,773	3,933	5,810
Nonmalignant Claims	5,420	5,334	6,492

REPOSITIONING AND OTHER CHARGES

3 Months Ended

Mar. 31, 2015

Repositioning And Other Charges [Abstract]

Repositioning and Other Charges

Note 3. Repositioning and Other Charges


	A summary of repositioning and other charges follows:

			Three Months Ended
			March 31,
			2015		2014
Severance		$	37	$	71
Asset impairments			8		9
Exit costs			1		8
Adjustments			(7)		(6)
Total net repositioning charge			39		82

Asbestos related litigation charges,
net of insurance			46		48
Probable and reasonably estimable
environmental liabilities			46		82
Other			-		2

Total net repositioning and other charges		$	131	$	214

The following table summarizes the pretax distribution of total net repositioning and other charges by income statement classification:

		Three Months Ended
		March 31,
		2015		2014
Cost of products and services sold	$	122	$	191
Selling, general and administrative expenses		9		23
	$	131	$	214

The following table summarizes the pretax impact of total net repositioning and other charges by segment:

		Three Months Ended
		March 31,
		2015		2014
Aerospace	$	48	$	76
Automation and Control Solutions		24		46
Performance Materials and Technologies		7		14
Corporate		52		78
	$	131	$	214

In the quarter ended March 31, 2015, we recognized repositioning charges totaling $46 million including severance costs of $37 million related to workforce reductions of 3,040 manufacturing and administrative positions across our segments. The workforce reductions were primarily related to cost savings actions taken in connection with our productivity and ongoing functional transformation initiatives and outsourcing of certain component manufacturing in our Automation and Control Solutions (ACS) segment.

In the quarter ended March 31, 2014, we recognized repositioning charges totaling $88 million including severance costs of $71 million related to workforce reductions of 1,520 manufacturing and administrative positions across our segments. The workforce reductions were primarily related to cost savings actions taken in connection with our productivity and ongoing functional transformation initiatives, factory transitions in ACS to more cost-effective locations, site consolidations and organizational realignments of businesses in ACS.

The following table summarizes the status of our total repositioning reserves:

		Severance		Asset		Exit
		Costs		Impairments		Costs		Total
December 31, 2014	$	285	$	-	$	30	$	315
Charges		37		8		1		46
Usage - cash		(24)		-		(3)		(27)
Usage - noncash		-		(8)		-		(8)
Foreign currency translation		(9)		-		(2)		(11)
Adjustments		(3)		-		(4)		(7)
March 31, 2015	$	286	$	-	$	22	$	308

Certain repositioning projects in our segments in 2015 and 2014 included exit or disposal activities, the costs related to which will be recognized in future periods when the actual liability is incurred. Such exit and disposal costs were not significant.

REPOSITIONING AND OTHER CHARGES (Tables)

3 Months Ended

Mar. 31, 2015

Repositioning And Other Charges [Abstract]

Repositioning and other charges text block


	A summary of repositioning and other charges follows:

			Three Months Ended
			March 31,
			2015		2014
Severance		$	37	$	71
Asset impairments			8		9
Exit costs			1		8
Adjustments			(7)		(6)
Total net repositioning charge			39		82

Asbestos related litigation charges,
net of insurance			46		48
Probable and reasonably estimable
environmental liabilities			46		82
Other			-		2

Total net repositioning and other charges		$	131	$	214

Pretax distribution of total net repositioning and other charges by income statement classification

The following table summarizes the pretax distribution of total net repositioning and other charges by income statement classification:

		Three Months Ended
		March 31,
		2015		2014
Cost of products and services sold	$	122	$	191
Selling, general and administrative expenses		9		23
	$	131	$	214

Pretax Impact of Total Net Repositioning and Other Charges by Segment

The following table summarizes the pretax impact of total net repositioning and other charges by segment:

		Three Months Ended
		March 31,
		2015		2014
Aerospace	$	48	$	76
Automation and Control Solutions		24		46
Performance Materials and Technologies		7		14
Corporate		52		78
	$	131	$	214

Total Repositioning Reserves

The following table summarizes the status of our total repositioning reserves:

		Severance		Asset		Exit
		Costs		Impairments		Costs		Total
December 31, 2014	$	285	$	-	$	30	$	315
Charges		37		8		1		46
Usage - cash		(24)		-		(3)		(27)
Usage - noncash		-		(8)		-		(8)
Foreign currency translation		(9)		-		(2)		(11)
Adjustments		(3)		-		(4)		(7)
March 31, 2015	$	286	$	-	$	22	$	308

CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Mar. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 6,575	$ 6,959
Accounts, notes and other receivables	8,158	7,960
Inventories	4,507	4,405
Deferred income taxes	656	722
Investments and other current assets	2,376	2,145
Total current assets	22,272	22,191
Investments and long-term receivables	464	465
Property, plant and equipment - net	5,300	5,383
Goodwill	12,685	12,788
Other intangible assets - net	2,190	2,208
Insurance recoveries for asbestos related liabilities	445	454
Deferred income taxes	329	404
Other assets	1,672	1,558
Total assets	45,357	45,451
Current liabilities:
Accounts payable	5,263	5,365
Short-term borrowings	47	51
Commercial paper	2,695	1,647
Current maturities of long-term debt	1,304	939
Accrued liabilities	6,123	6,771
Total current liabilities	15,432	14,773
Long-term debt	5,661	6,046
Deferred income taxes	210	236
Postretirement benefit obligations other than pensions	911	911
Asbestos related liabilities	1,197	1,200
Other liabilities	4,027	4,282
Redeemable noncontrolling interest	242	219
SHAREOWNERS' EQUITY
Capital - common stock issued	958	958
Capital - additional paid in capital	5,153	5,038
Common stock held in treasury, at cost	(10,281)	(9,995)
Accumulated other comprehensive loss	(2,099)	(1,459)
Retained earnings	23,811	23,115
Total Honeywell shareowners' equity	17,542	17,657
Noncontrolling interest	135	127
Total shareowners' equity	17,677	17,784
Total liabilities, redeemable noncontrolling interest, and shareowners' equity	$ 45,357	$ 45,451

INVENTORIES (Details) - USD ($) $ in Millions	Mar. 31, 2015	Dec. 31, 2014
Inventory Combining Work In Process And Raw Materials Alternative Gross Abstract
Raw materials	$ 1,088	$ 1,124
Work in process	828	815
Finished products	2,708	2,634
Inventory, Gross	4,624	4,573
Reduction to LIFO cost basis	(117)	(168)
Inventories	$ 4,507	$ 4,405

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

3 Months Ended

Mar. 31, 2015

Accumulated Other Comprehensive Income Loss [Abstract]

Accumulated Other Comprehensive Income (Loss)

Note 9. Accumulated Other Comprehensive Income (Loss)

Changes in Accumulated Other Comprehensive Income by Component

							Changes in		Changes in
			Foreign		Pension		Fair Value		Fair Value
			Exchange		and Other		of Available		of Effective
			Translation		Postretirement		for Sale		Cash Flow
			Adjustment		Adjustments		Investments		Hedges		Total

Balance at December 31, 2014		$	(740)	$	(728)	$	-	$	9	$	(1,459)
	Other comprehensive income
	(loss) before reclassifications		(721)		-		-		105		(616)
	Amounts reclassified from
	accumulated other
	comprehensive income		-		3		-		(27)		(24)
	Net current period other
	comprehensive income (loss)		(721)		3		-		78		(640)
Balance at March 31, 2015		$	(1,461)	$	(725)	$	-	$	87	$	(2,099)

							Changes in		Changes in
			Foreign		Pension		Fair Value		Fair Value
			Exchange		and Other		of Available		of Effective
			Translation		Postretirement		for Sale		Cash Flow
			Adjustment		Adjustments		Investments		Hedges		Total

Balance at December 31, 2013		$	304	$	355	$	170	$	(11)	$	818
	Other comprehensive income
	(loss) before reclassifications		(5)		-		(11)		9		(7)
	Amounts reclassified from
	accumulated other
	comprehensive income		-		4		(71)		4		(63)
	Net current period other
	comprehensive income (loss)		(5)		4		(82)		13		(70)
Balance at March 31, 2014		$	299	$	359	$	88	$	2	$	748

- Definition

The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

+ Details

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Mar. 31, 2015

Commitments And Contingencies [Abstract]

Commitments and Contingencies

Note 12. Commitments and Contingencies

Environmental Matters

Our environmental matters are described in Note 19, Commitments and Contingencies, of Notes to Financial Statements in our 2014 Annual Report on Form 10-K.

The following table summarizes information concerning our recorded liabilities for environmental costs:

December 31, 2014	$	591
Accruals for environmental matters deemed
probable and reasonably estimable		46
Environmental liability payments		(35)
March 31, 2015	$	602

Environmental liabilities are included in the following balance sheet accounts:

			March 31,		December 31,
			2015		2014
	Accrued liabilities	$	278	$	278
	Other liabilities		324		313
		$	602	$	591

Onondaga Lake, Syracuse, NY—We are implementing a combined dredging/capping remedy of Onondaga Lake pursuant to a consent decree approved by the United States District Court for the Northern District of New York in January 2007. We have accrued for our estimated cost of remediating Onondaga Lake based on currently available information and analysis performed by our engineering consultants. Honeywell is also conducting remedial investigations and activities at other sites in Syracuse. We have recorded reserves for these investigations and activities where appropriate, consistent with our accounting policy.

Honeywell has entered into a cooperative agreement with potential natural resource trustees to assess alleged natural resource damages relating to this site. It is not possible to predict the outcome or duration of this assessment, or the amounts of, or responsibility for, any damages.

Asbestos Matters

Honeywell is a defendant in asbestos related personal injury actions related to two predecessor companies:

North American Refractories Company (NARCO), which was sold in 1986, produced refractory products (bricks and cement used in high temperature applications). Claimants consist largely of individuals who allege exposure to NARCO asbestos-containing refractory products in an occupational setting.
Bendix Friction Materials (Bendix), which was sold in 2014, manufactured automotive brake parts that contained chrysotile asbestos in an encapsulated form. Claimants consist largely of individuals who allege exposure to asbestos from brakes from either performing or being in the vicinity of individuals who performed brake replacements.

The following tables summarize information concerning NARCO and Bendix asbestos related balances:

Asbestos Related Liabilities
		Bendix		NARCO		Total
December 31, 2014	$	623	$	929	$	1,552
Accrual for update to estimated liability		48		1		49
Asbestos related liability payments		(49)		(3)		(52)
March 31, 2015	$	622	$	927	$	1,549

Insurance Recoveries for Asbestos Related Liabilities
		Bendix		NARCO		Total
December 31, 2014	$	135	$	350	$	485
Probable insurance recoveries related to
estimated liability		5		-		5
Insurance receivables settlements		1		-		1
Insurance receipts for asbestos related liabilities		(7)		(7)		(14)
March 31, 2015	$	134	$	343	$	477

NARCO and Bendix asbestos related balances are included in the following balance sheet accounts:

		March 31,		December 31,
		2015		2014
Other current assets	$	32	$	31
Insurance recoveries for asbestos related liabilities		445		454
	$	477	$	485

Accrued liabilities	$	352	$	352
Asbestos related liabilities		1,197		1,200
	$	1,549	$	1,552

NARCO Products –In connection with NARCO’s emergence from bankruptcy on April 30, 2013, a federally authorized 524(g) trust (NARCO Trust) was established for the evaluation and resolution of all existing and future NARCO asbestos claims. Both Honeywell and NARCO are protected by a permanent channeling injunction barring all present and future individual actions in state or federal courts and requiring all asbestos related claims based on exposure to NARCO products to be made against the NARCO Trust. The NARCO Trust reviews submitted claims and determines award amounts in accordance with established Trust Distribution Procedures approved by the Bankruptcy Court which set forth the criteria claimants must meet to qualify for compensation including, among other things, exposure and medical criteria that determine the award amount. In addition, Honeywell provided, and continues to provide, input to the design of control procedures for processing NARCO claims, and has on-going audit rights to review and monitor the claims processors’ adherence to the established requirements of the Trust Distribution Procedures.

Honeywell is obligated to fund NARCO asbestos claims submitted to the NARCO Trust which qualify for payment under the Trust Distribution Procedures (Annual Contribution Claims), subject to annual caps of $140 million in the years 2015 through 2018 and $145 million for each year thereafter. However, the initial $100 million of claims processed through the NARCO Trust (the Initial Claims Amount) will not count against the annual cap and any unused portion of the Initial Claims Amount will roll over to subsequent years until fully utilized. As of March 31, 2015, Honeywell has not made any payments to the NARCO Trust for Annual Contribution Claims.

Honeywell is also responsible for payments due to claimants pursuant to settlement agreements reached during the pendency of the NARCO bankruptcy proceedings that provide for the right to submit claims to the NARCO Trust subject to qualification under the terms of the settlement agreements and Trust Distribution Procedures criteria (Pre-established Unliquidated Claims), which amounts are expected to be paid during the initial years of trust operations. Such payments are not subject to the annual cap described above.

Our consolidated financial statements reflect an estimated liability for Pre-established Unliquidated Claims ($147 million), unsettled claims pending as of the time NARCO filed for bankruptcy protection ($37 million) and for the estimated value of future NARCO asbestos claims expected to be asserted against the NARCO Trust through 2018 ($743 million). In the absence of actual trust experience on which to base the estimate, Honeywell projected the probable value of asbestos related future liabilities, including trust claim handling costs, based on a commonly accepted methodology used by numerous bankruptcy courts addressing 524(g) trusts. Some critical assumptions underlying this methodology include claims filing rates, disease criteria and payment values contained in the Trust Distribution Procedures, estimated approval rates of claims submitted to the NARCO Trust and epidemiological studies estimating disease instances. This projection resulted in a range of estimated liability of $743 million to $961 million. We believe that no amount within this range is a better estimate than any other amount and accordingly, we have recorded the minimum amount in the range. In light of the uncertainties inherent in making long-term projections and in connection with the recent implementation of the Trust Distribution Procedures by the NARCO Trust, as well as the stay of all NARCO asbestos claims which remained in place throughout NARCO’s Chapter 11 case, we do not believe that we have a reasonable basis for estimating NARCO asbestos claims beyond 2018.

Our insurance receivable corresponding to the estimated liability for pending and future NARCO asbestos claims reflects coverage which reimburses Honeywell for portions of NARCO-related indemnity and defense costs and is provided by a large number of insurance policies written by dozens of insurance companies in both the domestic insurance market and the London excess market. We conduct analyses to estimate the probable amount of insurance that is recoverable for asbestos claims. While the substantial majority of our insurance carriers are solvent, some of our individual carriers are insolvent, which has been considered in our analysis of probable recoveries. We made judgments concerning insurance coverage that we believe are reasonable and consistent with our historical dealings and our knowledge of any pertinent solvency issues surrounding insurers.

Projecting future events is subject to many uncertainties that could cause the NARCO-related asbestos liabilities or assets to be higher or lower than those projected and recorded. Given the uncertainties, we review our estimates periodically, and update them based on our experience and other relevant factors. Similarly, we will reevaluate our projections concerning our probable insurance recoveries in light of any changes to the projected liability or other developments that may impact insurance recoveries.

Friction Products—The following tables present information regarding Bendix related asbestos claims activity:

	Three Months Ended		Years Ended
	March 31,		December 31,
Claims Activity		2015	2014	2013
Claims Unresolved at the beginning of period		9,267	12,302	23,141
Claims Filed		707	3,694	4,527
Claims Resolved ^(a)		(781)	(6,729)	(15,366)
Claims Unresolved at the end of period		9,193	9,267	12,302

(a) Claims resolved in 2014 include 2,110 cancer claims which were determined to have no value. Also, claims resolved in 2014 and 2013 included significantly aged (i.e., pending for more than six years) claims totaling 1,266 and 12,250, respectively, of which 82% and 92%, respectively, were non-malignant.


Disease Distribution of Unresolved Claims	March 31,	December 31,
	2015	2014	2013
Mesothelioma and Other Cancer Claims	3,773	3,933	5,810
Nonmalignant Claims	5,420	5,334	6,492
Total Claims	9,193	9,267	12,302

	Honeywell has experienced average resolution values per claim excluding legal costs as follows:

			Years Ended December 31,
			2014		2013		2012		2011		2010
			(in whole dollars)
Malignant claims		$	53,500	$	51,000	$	49,000	$	48,000	$	54,000
Nonmalignant claims		$	120	$	850	$	1,400	$	1,000	$	1,300

It is not possible to predict whether resolution values for Bendix-related asbestos claims will increase, decrease or stabilize in the future.

Our consolidated financial statements reflect an estimated liability for resolution of pending (claims actually filed as of the financial statement date) and future Bendix-related asbestos claims. We have valued Bendix pending and future claims using average resolution values for the previous five years. We update the resolution values used to estimate the cost of Bendix pending and future claims during the fourth quarter each year.

The liability for future claims represents the estimated value of future asbestos related bodily injury claims expected to be asserted against Bendix over the next five years. Such estimated cost of future Bendix-related asbestos claims is based on historic claims filing experience and dismissal rates, disease classifications, and resolution values in the tort system for the previous five years. In light of the uncertainties inherent in making long-term projections, as well as certain factors unique to friction product asbestos claims, we do not believe that we have a reasonable basis for estimating asbestos claims beyond the next five years. The methodology used to estimate the liability for future claims is similar to that used to estimate the liability for future NARCO-related asbestos claims.

Our insurance receivable corresponding to the liability for settlement of pending and future Bendix asbestos claims reflects coverage which is provided by a large number of insurance policies written by dozens of insurance companies in both the domestic insurance market and the London excess market. Based on our ongoing analysis of the probable insurance recovery, insurance receivables are recorded in the financial statements simultaneous with the recording of the estimated liability for the underlying asbestos claims. This determination is based on our analysis of the underlying insurance policies, our historical experience with our insurers, our ongoing review of the solvency of our insurers, judicial determinations relevant to our insurance programs, and our consideration of the impacts of any settlements reached with our insurers.

Honeywell believes it has sufficient insurance coverage and reserves to cover all pending Bendix-related asbestos claims and Bendix-related asbestos claims estimated to be filed within the next five years. Although it is impossible to predict the outcome of either pending or future Bendix-related asbestos claims, we do not believe that such claims would have a material adverse effect on our consolidated financial position in light of our insurance coverage and our prior experience in resolving such claims. If the rate and types of claims filed, the average resolution value of such claims and the period of time over which claim settlements are paid (collectively, the Variable Claims Factors) do not substantially change, Honeywell would not expect future Bendix-related asbestos claims to have a material adverse effect on our results of operations or operating cash flows in any fiscal year. No assurances can be given, however, that the Variable Claims Factors will not change.

Other Matters

Honeywell v. United Auto Workers (UAW) et. al—In July 2011, Honeywell filed an action in federal court (District of New Jersey) against the UAW and all former employees who retired under a series of Master Collective Bargaining Agreements (MCBAs) between Honeywell and the UAW seeking a declaratory judgment that certain express limitations on its obligation to contribute toward the healthcare coverage of such retirees (the CAPS) set forth in the MCBAs may be implemented, effective January 1, 2012. The UAW and certain retiree defendants filed a mirror suit in the Eastern District of Michigan alleging that the MCBAs do not provide for CAPS on the Company’s liability for healthcare coverage. The New Jersey action was dismissed and Honeywell subsequently answered the UAW’s complaint in Michigan and asserted counterclaims for fraudulent inducement, negligent misrepresentation and breach of implied warranty. The UAW filed a motion to dismiss these counterclaims. The court dismissed Honeywell’s fraudulent inducement and negligent misrepresentation claims, but let stand the claim for breach of implied warranty. In the second quarter of 2014, the parties agreed to stay the proceedings with respect to those retirees who retired before the initial inclusions of the CAPS in the 2003 MCBA until the Supreme Court decided the M&G Polymers USA, LLC v. Tackett case. In a ruling on January 26, 2015, the Supreme Court held that retiree health insurance benefits provided in collective bargaining agreements do not carry an inference that they are vested or guaranteed to continue for life and that the “vesting” issue must be decided pursuant to ordinary principles of contract law. Based on this ruling, Honeywell is confident that the CAPS will be upheld and that its liability for healthcare coverage premiums with respect to the putative class will be limited as negotiated and expressly set forth in the applicable MCBAs. In the event of an adverse ruling, however, Honeywell’s other postretirement benefits for pre-2003 retirees would increase by approximately $180 million, reflecting the estimated value of these CAPS.

In December 2013, the UAW and certain of the plaintiffs filed a motion for partial summary judgment with respect to those retirees who retired after the initial inclusion of the CAPS in the 2003 MCBA. The UAW sought a ruling that the 2003 MCBA did not limit Honeywell’s obligation to contribute to healthcare coverage for the post-2003 retirees. That motion remains pending. Honeywell is confident that the Court will find that the 2003 MCBA does, in fact, limit Honeywell’s retiree healthcare obligation for post-2003 retirees. In the event of an adverse ruling, however, Honeywell’s other postretirement benefits for post-2003 retirees would increase by approximately $120 million, reflecting the estimated value of these CAPS.

Joint Strike Fighter Investigation - In 2013 the Company received subpoenas from the Department of Justice requesting information relating primarily to parts manufactured in the United Kingdom and China used in the F-35 fighter jet. The Company is cooperating fully with the investigation. While we believe that Honeywell has complied with all relevant U.S. laws and regulations regarding the manufacture of these sensors, it is not possible to predict the outcome of the investigation or what action, if any, may result from it.

Given the uncertainty inherent in litigation and investigations (including the specific matters referenced above), we do not believe it is possible to develop estimates of reasonably possible loss in excess of current accruals for these matters (other than as specifically set forth above). Considering our past experience and existing accruals, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our consolidated financial position. Because most contingencies are resolved over long periods of time, potential liabilities are subject to change due to new developments, changes in settlement strategy or the impact of evidentiary requirements, which could cause us to pay damage awards or settlements (or become subject to equitable remedies) that could have a material adverse effect on our results of operations or operating cash flows in the periods recognized or paid.

REPOSITIONING AND OTHER CHARGES 3 (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	$ 131	$ 214
Aerospace [Member]
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	48	76
Automation and Control Solutions [Member]
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	24	46
Performance Materials And Technologies [Member]
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	7	14
Corporate [Member]
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	$ 52	$ 78

SEGMENT FINANCIAL DATA (Tables)

3 Months Ended

Mar. 31, 2015

Segment Financial Data [Abstract]

Segment Financial Data

		Three Months Ended
		March 31,
		2015		2014
Net Sales
Aerospace
Products	$	2,463	$	2,692
Services		1,144		1,159
Total		3,607		3,851
Automation and Control Solutions
Products		2,979		3,075
Services		285		287
Total		3,264		3,362
Performance Materials and Technologies
Products		1,922		2,078
Services		420		388
Total		2,342		2,466
	$	9,213	$	9,679

Segment Profit
Aerospace	$	752	$	703
Automation and Control Solutions		516		471
Performance Materials and Technologies		503		473
Corporate		(50)		(51)
Total segment profit		1,721		1,596

Other income (expense)^(a)		12		111
Interest and other financial charges		(77)		(79)
Stock compensation expense^(b)		(52)		(52)
Pension ongoing income^(b)		100		61
Other postretirement expense^(b)		(9)		(12)
Repositioning and other charges ^(b)		(131)		(214)
Income before taxes	$	1,564	$	1,411

(a) Equity income (loss) of affiliated companies is included in segment profit.

(b) Amounts included in cost of products and services sold and selling, general and administrative expenses.

COMMITMENTS AND CONTINGENCIES (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Environmental Matters [Abstract]
Beginning of period	$ 591
Accruals for environmental matters deemed probable and reasonably estimable	46
Environmental liability payments	(35)
End of period	602
Loss Contingency Classification of Accrual [Abstract]
Accrued liabilities	278	$ 278
Other liabilities	324	313
Total environmental liabilities	$ 602	$ 591

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Details) - Significant Observable Inputs (Level 2) - USD ($) $ in Millions	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale investments	$ 1,767	$ 1,479
Foreign Currency Exchange Contracts [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Fair Value Of Derivative Asset	135	20
Derivative Fair Value Of Derivative Liability	29	10
Interest Rate Swap Agreements [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Fair Value Of Derivative Asset	$ 108	$ 93

COMMITMENTS AND CONTINGENCIES 9 (Details)	3 Months Ended
COMMITMENTS AND CONTINGENCIES 9 (Details)	Mar. 31, 2015
Joint Strike Fighter [Member]
Other Matters Paragraph Details 2 [Line Items]
Loss Contingency Request For Information	In 2013 the Company received subpoenas from the Department of Justice requesting information relating primarily to parts manufactured in the United Kingdom and China used in the F-35 fighter jet. The Company is cooperating fully with the investigation. While we believe that Honeywell has complied with all relevant U.S. laws and regulations regarding the manufacture of these sensors, it is not possible to predict the outcome of the investigation or what action, if any, may result from it.

PENSION BENEFITS (Tables)

3 Months Ended

Mar. 31, 2015

Pension Benefits (Tables) [Abstract]

Defined Benefit Plans Disclosure

		Three Months Ended
		U.S. Plans				Non-U.S. Plans
		March 31,				March 31,
		2015		2014		2015		2014

Service cost	$	57	$	60	$	13	$	14
Interest cost		178		193		44		58
Expected return on plan assets		(320)		(314)		(90)		(89)
Amortization of prior service cost		6		6		-		-
	$	(79)	$	(55)	$	(33)	$	(17)

COMMITMENTS AND CONTINGENCIES 7 (Details) - Bendix Asbestos Loss Contingency Liability [Member] - $ / claims	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Resolution Values Per Claim [Line Items]
Malignant claims	53,500	51,000	49,000	48,000	54,000
Nonmalignant claims	120	850	1,400	1,000	1,300

Label	Element	Value
Bendix Asbestos Loss Contingency Liability [Member]
Loss Contingency Pending Claims Number	us-gaap_LossContingencyPendingClaimsNumber	9,193
Loss Contingency Pending Claims Number	us-gaap_LossContingencyPendingClaimsNumber	9,267
Loss Contingency Pending Claims Number	us-gaap_LossContingencyPendingClaimsNumber	12,302

REPOSITIONING AND OTHER CHARGES 2 (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Cost of products and services sold	$ 6,362	$ 6,967
Selling, general and administrative expenses	1,230	1,339
Total net repositioning and other charges	131	214
Restructuring Charges [Member]
Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Cost of products and services sold	122	191
Selling, general and administrative expenses	9	23
Total net repositioning and other charges	$ 131	$ 214

EARNINGS (LOSS) PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Earnings Per Share [Abstract]
Net income attributable to Honeywell	$ 1,116	$ 1,017
Weighted average shares outstanding	783.8	784.9
Earnings per share of common stock - basic	$ 1.42	$ 1.3
Assuming dilution
Net income attributable to Honeywell	$ 1,116	$ 1,017
Average shares
Weighted average shares outstanding	783.8	784.9
Dilutive securities issuable - stock plans	10.2	11.5
Total weighted average diluted shares outstanding	794.0	796.4
Earnings per share of common stock - assuming dilution	$ 1.41	$ 1.28
Earnings Per Share Paragraph Details [Abstract]
Stock options excluded from diluted computations	7.8	2.0

COMMITMENTS AND CONTINGENCIES (Tables)

3 Months Ended

Mar. 31, 2015

Commitments And Contingencies [Abstract]

Loss Contingency

December 31, 2014	$	591
Accruals for environmental matters deemed
probable and reasonably estimable		46
Environmental liability payments		(35)
March 31, 2015	$	602

Environmental liabilities are included in the following balance sheet accounts:

Environmental liabilities are included in the following balance sheet accounts:

			March 31,		December 31,
			2015		2014
	Accrued liabilities	$	278	$	278
	Other liabilities		324		313
		$	602	$	591

Asbestos Related Liabilities

Asbestos Related Liabilities
		Bendix		NARCO		Total
December 31, 2014	$	623	$	929	$	1,552
Accrual for update to estimated liability		48		1		49
Asbestos related liability payments		(49)		(3)		(52)
March 31, 2015	$	622	$	927	$	1,549

Insurance Recoveries for Asbestos Related Liabilities

Insurance Recoveries for Asbestos Related Liabilities
		Bendix		NARCO		Total
December 31, 2014	$	135	$	350	$	485
Probable insurance recoveries related to
estimated liability		5		-		5
Insurance receivables settlements		1		-		1
Insurance receipts for asbestos related liabilities		(7)		(7)		(14)
March 31, 2015	$	134	$	343	$	477

NARCO and Bendix asbestos related balances are included in the following balance sheet accounts

NARCO and Bendix asbestos related balances are included in the following balance sheet accounts:

		March 31,		December 31,
		2015		2014
Other current assets	$	32	$	31
Insurance recoveries for asbestos related liabilities		445		454
	$	477	$	485

Accrued liabilities	$	352	$	352
Asbestos related liabilities		1,197		1,200
	$	1,549	$	1,552

The following tables present information regarding Bendix related asbestos claims activity

	Three Months Ended		Years Ended
	March 31,		December 31,
Claims Activity		2015	2014	2013
Claims Unresolved at the beginning of period		9,267	12,302	23,141
Claims Filed		707	3,694	4,527
Claims Resolved ^(a)		(781)	(6,729)	(15,366)
Claims Unresolved at the end of period		9,193	9,267	12,302

(a) Claims resolved in 2014 include 2,110 cancer claims which were determined to have no value. Also, claims resolved in 2014 and 2013 included significantly aged (i.e., pending for more than six years) claims totaling 1,266 and 12,250, respectively, of which 82% and 92%, respectively, were non-malignant.

Disease distribution of claims


Disease Distribution of Unresolved Claims	March 31,	December 31,
	2015	2014	2013
Mesothelioma and Other Cancer Claims	3,773	3,933	5,810
Nonmalignant Claims	5,420	5,334	6,492
Total Claims	9,193	9,267	12,302

Average resolution values per asbestos claim

	Honeywell has experienced average resolution values per claim excluding legal costs as follows:

			Years Ended December 31,
			2014		2013		2012		2011		2010
			(in whole dollars)
Malignant claims		$	53,500	$	51,000	$	49,000	$	48,000	$	54,000
Nonmalignant claims		$	120	$	850	$	1,400	$	1,000	$	1,300

LONG-TERM DEBT AND CREDIT AGREEMENTS (Tables)

3 Months Ended

Mar. 31, 2015

Long Term Debt And Credit Agreements [Abstract]

Long-Term Debt and Credit Agreements

		March 31,		December 31,
		2015		2014

Floating rate notes due 2015	$	700	$	700
5.40% notes due 2016		400		400
5.30% notes due 2017		400		400
5.30% notes due 2018		900		900
5.00% notes due 2019		900		900
4.25% notes due 2021		800		800
3.35% notes due 2023		300		300
5.70% notes due 2036		550		550
5.70% notes due 2037		600		600
5.375% notes due 2041		600		600
Industrial development bond obligations, floating
rate maturing at various dates through 2037		30		30
6.625% debentures due 2028		216		216
9.065% debentures due 2033		51		51
Other (including capitalized leases), 0.6%-9.5%
maturing at various dates through 2023		518		538
		6,965		6,985
Less: current portion		(1,304)		(939)
	$	5,661	$	6,046

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5

+ Details

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)

3 Months Ended

Mar. 31, 2015

Accumulated Other Comprehensive Income (Loss) [Abstract]

Changes in Accumulated Other Comprehensive Income by Component

Changes in Accumulated Other Comprehensive Income by Component

							Changes in		Changes in
			Foreign		Pension		Fair Value		Fair Value
			Exchange		and Other		of Available		of Effective
			Translation		Postretirement		for Sale		Cash Flow
			Adjustment		Adjustments		Investments		Hedges		Total

Balance at December 31, 2014		$	(740)	$	(728)	$	-	$	9	$	(1,459)
	Other comprehensive income
	(loss) before reclassifications		(721)		-		-		105		(616)
	Amounts reclassified from
	accumulated other
	comprehensive income		-		3		-		(27)		(24)
	Net current period other
	comprehensive income (loss)		(721)		3		-		78		(640)
Balance at March 31, 2015		$	(1,461)	$	(725)	$	-	$	87	$	(2,099)

							Changes in		Changes in
			Foreign		Pension		Fair Value		Fair Value
			Exchange		and Other		of Available		of Effective
			Translation		Postretirement		for Sale		Cash Flow
			Adjustment		Adjustments		Investments		Hedges		Total

Balance at December 31, 2013		$	304	$	355	$	170	$	(11)	$	818
	Other comprehensive income
	(loss) before reclassifications		(5)		-		(11)		9		(7)
	Amounts reclassified from
	accumulated other
	comprehensive income		-		4		(71)		4		(63)
	Net current period other
	comprehensive income (loss)		(5)		4		(82)		13		(70)
Balance at March 31, 2014		$	299	$	359	$	88	$	2	$	748

BASIS OF PRESENTATION	3 Months Ended
BASIS OF PRESENTATION	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation [Text Block]	Note 1. Basis of Presentation In the opinion of management, the accompanying unaudited consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position of Honeywell International Inc. and its consolidated subsidiaries (Honeywell or the Company) at March 31, 2015 and the results of operations and cash flows for the three months ended March 31, 2015 and 2014. The results of operations for the three months ended March 31, 2015 should not necessarily be taken as indicative of the results of operations that may be expected for the entire year. We report our quarterly financial information using a calendar convention; that is, the first, second and third quarters are consistently reported as ending on March 31, June 30 and September 30. It has been our practice to establish actual quarterly closing dates using a predetermined fiscal calendar, which requires our businesses to close their books on a Saturday in order to minimize the potentially disruptive effects of quarterly closing on our business processes. The effects of this practice are generally not significant to reported results for any quarter and only exist within a reporting year. If differences in actual closing dates are material to year-over-year comparisons of quarterly or year-to-date results, we provide appropriate disclosures. Our actual closing dates for the three months ended March 31, 2015 and 2014 were March 28, 2015 and March 29, 2014. Certain prior year amounts have been reclassified to conform to current year presentation.

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 1,146,000,000	$ 1,036,000,000
Other Comprehensive Income (Loss), Net Of Tax [Abstract]
Foreign exchange translation adjustment	(721,000,000)	(5,000,000)
Actuarial (losses) gains recognized	(2,000,000)	4,000,000
Prior service costs recognized	5,000,000	0
Pension and other postretirement benefit adjustments	3,000,000	4,000,000
Unrealized losses	0	(11,000,000)
Less: Reclassification adjustment for gains included in net income	0	71,000,000
Changes in fair value of available for sale investments	0	(82,000,000)
Effective portion of cash flow hedges recognized in other comprehensive income	105,000,000	9,000,000
Less: Reclassification adjustment for gains (losses) included in net income	27,000,000	(4,000,000)
Changes in fair value of effective cash flow hedges	78,000,000	13,000,000
Other comprehensive loss, net of tax	(640,000,000)	(70,000,000)
Comprehensive income	506,000,000	966,000,000
Less: Comprehensive income attributable to the noncontrolling interest	30,000,000	19,000,000
Comprehensive income attributable to Honeywell	$ 476,000,000	$ 947,000,000

EARNINGS (LOSS) PER SHARE (Tables)

3 Months Ended

Mar. 31, 2015

Earnings Per Share (Tables) [Abstract]

Earnings per share basic

		Three Months Ended
		March 31,
Basic		2015		2014

Net income attributable to Honeywell	$	1,116	$	1,017

Weighted average shares outstanding		783.8		784.9

Earnings per share of common stock	$	1.42	$	1.30

Earnings per share diluted


		Three Months Ended
		March 31,
Assuming Dilution		2015		2014

Net income attributable to Honeywell	$	1,116	$	1,017

Average Shares
Weighted average shares outstanding		783.8		784.9
Dilutive securities issuable - stock plans		10.2		11.5
Total weighted average shares outstanding		794.0		796.4

Earnings per share of common stock	$	1.41	$	1.28

SEGMENT FINANCIAL DATA

3 Months Ended

Mar. 31, 2015

Segment Financial Data [Abstract]

Segment Financial Data

Note 10. Segment Financial Data

Honeywell’s senior management evaluates segment performance based on segment profit. Segment profit is measured as business unit income (loss) before taxes excluding general corporate unallocated expense, other income (expense), interest and other financial charges, pension and other postretirement income (expense), stock compensation expense, repositioning and other charges and accounting changes.

		Three Months Ended
		March 31,
		2015		2014
Net Sales
Aerospace
Products	$	2,463	$	2,692
Services		1,144		1,159
Total		3,607		3,851
Automation and Control Solutions
Products		2,979		3,075
Services		285		287
Total		3,264		3,362
Performance Materials and Technologies
Products		1,922		2,078
Services		420		388
Total		2,342		2,466
	$	9,213	$	9,679

Segment Profit
Aerospace	$	752	$	703
Automation and Control Solutions		516		471
Performance Materials and Technologies		503		473
Corporate		(50)		(51)
Total segment profit		1,721		1,596

Other income (expense)^(a)		12		111
Interest and other financial charges		(77)		(79)
Stock compensation expense^(b)		(52)		(52)
Pension ongoing income^(b)		100		61
Other postretirement expense^(b)		(9)		(12)
Repositioning and other charges ^(b)		(131)		(214)
Income before taxes	$	1,564	$	1,411

(a) Equity income (loss) of affiliated companies is included in segment profit.

(b) Amounts included in cost of products and services sold and selling, general and administrative expenses.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

+ Details

CONSOLIDATED STATEMENT OF OPERATIONS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Consolidated Statement of Operations
Product sales	$ 7,364	$ 7,845
Service sales	1,849	1,834
Net Sales	9,213	9,679
Costs, expenses and other
Cost of products sold	5,213	5,779
Cost of services sold	1,149	1,188
Cost of products and services sold	6,362	6,967
Selling, general and administrative expenses	1,230	1,339
Other (income) expense	(20)	(117)
Interest and other financial charges	77	79
Cost, operating and non-operating expenses	7,649	8,268
Income before taxes	1,564	1,411
Tax expense	418	375
Net income	1,146	1,036
Less: Net income attributable to the noncontrolling interest	30	19
Net income attributable to Honeywell	$ 1,116	$ 1,017
Earnings per share of common stock - basic	$ 1.42	$ 1.3
Earnings per share of common stock - assuming dilution	1.41	1.28
Cash dividends per share of common stock	$ 0.5175	$ 0.45

COMMITMENTS AND CONTINGENCIES 8 (Details) - United Auto Workers [Member] $ in Millions	3 Months Ended
	Mar. 31, 2015 USD ($)
Pre-2003 Retirees [Member]
Other Matters Paragraph Details [Line Items]
Potential Opeb Increase Due To Adverse Ruling	$ 180
Post-2003 Retirees [Member]
Other Matters Paragraph Details [Line Items]
Potential Opeb Increase Due To Adverse Ruling	$ 120

COMMITMENTS AND CONTINGENCIES 4 (Details) - Narco Asbestos Loss Contingency Liability [Member] $ in Millions	Mar. 31, 2015 USD ($)
Loss Contingency By Nature Of Contingency [Line Items]
Loss Contingency Estimated Pre-established Unliquidated Claims Amount	$ 147
Loss Contingency Estimated Unsettled Claims Amount	37
Estimated Liability	743
Maximum Estimated Liability	961
Exceptions To Cap [Abstract]
Value Not Included In Cap	100
Years 2015 To 2018 [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Annual Trust Cap	140
Year 2019 And Thereafter [Member]
Loss Contingency By Nature Of Contingency [Line Items]
Annual Trust Cap	$ 145

LONG-TERM DEBT AND CREDIT AGREEMENTS

3 Months Ended

Mar. 31, 2015

Long Term Debt And Credit Agreements [Abstract]

Long-term Debt and Credit Agreements

Note 7. Long-term Debt

		March 31,		December 31,
		2015		2014

Floating rate notes due 2015	$	700	$	700
5.40% notes due 2016		400		400
5.30% notes due 2017		400		400
5.30% notes due 2018		900		900
5.00% notes due 2019		900		900
4.25% notes due 2021		800		800
3.35% notes due 2023		300		300
5.70% notes due 2036		550		550
5.70% notes due 2037		600		600
5.375% notes due 2041		600		600
Industrial development bond obligations, floating
rate maturing at various dates through 2037		30		30
6.625% debentures due 2028		216		216
9.065% debentures due 2033		51		51
Other (including capitalized leases), 0.6%-9.5%
maturing at various dates through 2023		518		538
		6,965		6,985
Less: current portion		(1,304)		(939)
	$	5,661	$	6,046

EARNINGS (LOSS) PER SHARE

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Earnings Per Share

Note 4. Earnings Per Share

		Three Months Ended
		March 31,
Basic		2015		2014

Net income attributable to Honeywell	$	1,116	$	1,017

Weighted average shares outstanding		783.8		784.9

Earnings per share of common stock	$	1.42	$	1.30


		Three Months Ended
		March 31,
Assuming Dilution		2015		2014

Net income attributable to Honeywell	$	1,116	$	1,017

Average Shares
Weighted average shares outstanding		783.8		784.9
Dilutive securities issuable - stock plans		10.2		11.5
Total weighted average shares outstanding		794.0		796.4

Earnings per share of common stock	$	1.41	$	1.28

The diluted earnings per share calculations exclude the effect of stock options when the options’ assumed proceeds exceed the average market price of the common shares during the period. For the three months ended March 31, 2015 and 2014, the weighted average number of stock options excluded from the computations was 7.8 million and 2.0 million, respectively. These stock options were outstanding at the end of each of the respective periods.

INVENTORIES (Tables)

3 Months Ended

Mar. 31, 2015

Inventories [Abstract]

Inventories

		March 31,		December 31,
		2015		2014

Raw materials	$	1,088	$	1,124
Work in process		828		815
Finished products		2,708		2,634
		4,624		4,573
Reduction to LIFO cost basis		(117)		(168)
	$	4,507	$	4,405

COMMITMENTS AND CONTINGENCIES 2 (Details)	3 Months Ended
COMMITMENTS AND CONTINGENCIES 2 (Details)	Mar. 31, 2015 USD ($)
Asbestos Related Liabilities Disclosure [Abstract]
Asbestos Related Liabilities, Beginning of Period	$ 1,552,000,000
Accrual for update to estimated liability	49,000,000
Asbestos related liability payments	(52,000,000)
Asbestos Related Liabilities, End of Period	1,549,000,000
Asbestos Related Liabilities Insurance Recoveries [Line Items]
Insurance Recoveries, beginning of period	485,000,000
Probable insurance recoveries related to estimated liability	5,000,000
Insurance receivables settlements	1,000,000
Insurance receipts for asbestos related liabilities	(14,000,000)
Insurance recoveries, end of period	477,000,000
Bendix Asbestos Loss Contingency Liability [Member]
Asbestos Related Liabilities Disclosure [Abstract]
Asbestos Related Liabilities, Beginning of Period	623,000,000
Accrual for update to estimated liability	48,000,000
Asbestos related liability payments	(49,000,000)
Asbestos Related Liabilities, End of Period	622,000,000
Asbestos Related Liabilities Insurance Recoveries [Line Items]
Insurance Recoveries, beginning of period	135,000,000
Probable insurance recoveries related to estimated liability	5,000,000
Insurance receivables settlements	1,000,000
Insurance receipts for asbestos related liabilities	(7,000,000)
Insurance recoveries, end of period	134,000,000
Narco Asbestos Loss Contingency Liability [Member]
Asbestos Related Liabilities Disclosure [Abstract]
Asbestos Related Liabilities, Beginning of Period	929,000,000
Accrual for update to estimated liability	1,000,000
Asbestos related liability payments	(3,000,000)
Asbestos Related Liabilities, End of Period	927,000,000
Asbestos Related Liabilities Insurance Recoveries [Line Items]
Insurance Recoveries, beginning of period	350,000,000
Probable insurance recoveries related to estimated liability	0
Insurance receivables settlements	0
Insurance receipts for asbestos related liabilities	(7,000,000)
Insurance recoveries, end of period	$ 343,000,000

COMMITMENTS AND CONTINGENCIES 5 (Details) - Bendix Asbestos Loss Contingency Liability [Member] - claims	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Loss Contingency Claims [Abstract]
Claims Unresolved at the beginning of period	9,267	12,302	23,141
Claims Filed during the period	707	3,694	4,527
Claims Resolved during the period	(781)	(6,729)	(15,366)
Claims Unresolved at the end of period	9,193	9,267	12,302
Loss Contingency Claims Footnote [Abstract]
Significantly Aged Claims		1,266	12,250
Significantly Aged Claims Nonmalignant Percent		82.00%	92.00%
Cancer Claims With No Determinable Value		2,110

RECENT ACCOUNTING PRONOUNCEMENTS	3 Months Ended
RECENT ACCOUNTING PRONOUNCEMENTS	Mar. 31, 2015
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]
Recent Accounting Pronouncements [Text Block]	Note 2. Recent Accounting Pronouncements The Company considers the applicability and impact of all accounting standard updates (ASUs). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on our consolidated financial position or results of operations. In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers that will supersede most current revenue recognition guidance, including industry-specific guidance. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The guidance provides a five-step analysis of transactions to determine when and how revenue is recognized. Other major provisions include capitalization of certain contract costs, consideration of time value of money in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The guidance also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. The guidance is effective for the interim and annual periods beginning on or after December 15, 2016 (early adoption is not permitted). The guidance permits the use of either a retrospective or cumulative effect transition method. We have not yet selected a transition method and are currently evaluating the impact of the amended guidance on our consolidated financial position, results of operations and related disclosures.

- Definition

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Direct Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6510796

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Indirect Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Accounting Change
-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Retrospective Application
-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e725-108305

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 01
-Paragraph b
-Subparagraph 6
-Article 10

+ Details

REPOSITIONING AND OTHER CHARGES 4 (Details) $ in Millions	3 Months Ended
REPOSITIONING AND OTHER CHARGES 4 (Details) $ in Millions	Mar. 31, 2015 USD ($) Employees	Mar. 31, 2014 USD ($) Employees
Net repositioning and other charges Paragraph Details [Abstract]
Gross Repositioning Charge	$ 46	$ 88
Number Of Employees Severed \| Employees	3,040	1,520
Net Repositioning And Other Charges [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 39	$ 82
Severance Costs [Member]
Net Repositioning And Other Charges [Line Items]
Restructuring and Related Cost, Incurred Cost	37	71
Tangible And Intangible Asset Impairment [Member]
Net Repositioning And Other Charges [Line Items]
Restructuring and Related Cost, Incurred Cost	8	9
Exit Costs [Member]
Net Repositioning And Other Charges [Line Items]
Restructuring and Related Cost, Incurred Cost	1	8
Restructuring Reserve Accrual Adjustments [Member]
Net Repositioning And Other Charges [Line Items]
Restructuring and Related Cost, Incurred Cost	$ (7)	$ (6)

ACCOUNTS, NOTES AND OTHER RECEIVABLES (Tables)

3 Months Ended

Mar. 31, 2015

Accounts, Notes And Other Receivables [Abstract]

Schedule of trade, notes, and other receivables


		March 31,		December 31,
		2015		2014

Trade	$	7,868	$	7,788
Other		557		445
		8,425		8,233
Less: Allowance for doubtful accounts		(267)		(273)
	$	8,158	$	7,960

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES 2 (Details) - USD ($) $ in Millions	Mar. 31, 2015	Dec. 31, 2014
Carrying (Reported) Amount, Fair Value Disclosure [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Long-term receivables	$ 297	$ 297
Long-term debt and related current maturities	6,965	6,985
Estimate of Fair Value, Fair Value Disclosure [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Long-term receivables	292	293
Long-term debt and related current maturities	$ 7,813	$ 7,817

LONG-TERM DEBT AND CREDIT AGREEMENTS (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Total long-term debt, including current portion	$ 6,965	$ 6,985
Less current portion	(1,304)	(939)
Total Noncurrent Debt	5,661	6,046
Floating Rate Notes Due 2015 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 700	700
Maturity date of debt instrument	Nov. 17, 2015
Notes 5.40% due 2016 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 400	400
Various interest rates	5.40%
Maturity date of debt instrument	Mar. 15, 2016
Notes 5.30% due 2017 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 400	400
Various interest rates	5.30%
Maturity date of debt instrument	Mar. 15, 2017
Notes 5.30% due 2018 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 900	900
Various interest rates	5.30%
Maturity date of debt instrument	Mar. 01, 2018
Notes 5.00% due 2019 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 900	900
Various interest rates	5.00%
Maturity date of debt instrument	Feb. 15, 2019
Notes 4.25% Due 2021 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 800	800
Various interest rates	4.25%
Maturity date of debt instrument	Mar. 01, 2021
Notes 3.35% Due 2023 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 300	300
Various interest rates	3.35%
Maturity date of debt instrument	Dec. 01, 2023
Notes 5.70% due 2036 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 550	550
Various interest rates	5.70%
Maturity date of debt instrument	Mar. 15, 2036
Notes 5.70% due 2037 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 600	600
Various interest rates	5.70%
Maturity date of debt instrument	Mar. 15, 2037
Notes 5.375% Due 2041 [Member]
Debt Instrument [Line Items]
Senior Notes	$ 600	600
Various interest rates	5.375%
Maturity date of debt instrument	Mar. 01, 2041
Industrial development bond obligations, floating rate maturing at various dates through 2037 [Member]
Debt Instrument [Line Items]
Industrial development bond	$ 30	30
Maturity date of debt instrument	Dec. 31, 2037
Debentures 6.625% due 2028 [Member]
Debt Instrument [Line Items]
Debentures	$ 216	216
Various interest rates	6.625%
Maturity date of debt instrument	Jun. 15, 2028
Debentures 9.065% due 2033 [Member]
Debt Instrument [Line Items]
Debentures	$ 51	51
Various interest rates	9.065%
Maturity date of debt instrument	Jun. 01, 2033
Other including capitalized leases, .6% To 9.5% maturing at various dates through 2023 [Member]
Debt Instrument [Line Items]
Other long term debt	$ 518	$ 538
Interest rate range minimum	0.60%
Interest rate range maximum	9.50%
Maturity date of debt instrument	Dec. 31, 2023

ACCOUNTS, NOTES AND OTHER RECEIVABLES (Details) - USD ($) $ in Millions	Mar. 31, 2015	Dec. 31, 2014
Accounts Receivable, Net Current [Abstract]
Trade	$ 7,868	$ 7,788
Other	557	445
Accounts receivable, Gross	8,425	8,233
Less - Allowance for doubtful accounts	(267)	(273)
Accounts receivable, Net	8,158	7,960
Accounts Notes, And Other Receivables Paragraph Details [Abstract]
Unbilled contract receivable	$ 1,730	$ 1,636

COMMITMENTS AND CONTINGENCIES 3 (Details) - USD ($) $ in Millions	Mar. 31, 2015	Dec. 31, 2014
Loss Contingency, Narco and Bendix Asbestos Related Balances by Balance Sheet Caption [Abstract]
Other current assets	$ 32	$ 31
Insurance recoveries for asbestos related liabilities	445	454
Total assets	477	485
Accrued liabilities	352	352
Asbestos related liabilities	1,197	1,200
Total liabilities	$ 1,549	$ 1,552